Alcanza Clinical Research

The findings in AMRC’s new whitepaper validate many of the trends we’re experiencing at Alcanza. As a purpose-built site network with deep community roots and a focus on inclusive access, we see how coordinated infrastructure and consistent operations can meaningfully improve trial delivery — especially for underrepresented populations. Yet too often, these strengths are undervalued in traditional definitions of research quality. We’re encouraged to see AMRC leading a broader industry conversation to define quality in ways that reflect how trials are actually delivered today. The consultation is open through 3 December. We encourage sponsors, CROs, and site stakeholders to contribute: https://lnkd.in/ekWPMxXS #clinicalresearch #AMRC #multisite #MCRC

Join us in celebrating the grand opening of Desert Clinical Research—Alcanza’s newest site in Henderson, Nevada—with an open house! Located in the Las Vegas metro area, the new site expands Alcanza’s Southwest footprint and features an on-site lab, pharmacy, and FibroScan technology—supporting late-stage trials and improving access in underrepresented communities. Local healthcare providers, patients and community partners are invited to tour the facility and connect with the team: Date: November 5th, 2025 Time: 3:30–6:00 PM Location: 2780 W. Horizon Ridge Pkwy, Henderson, NV 89052 Read the full announcement: https://lnkd.in/g7uuc7UT RSVP to the Open House: https://lnkd.in/gAa9bWET Association of Multisite Research Corporations hyperCORE International

Great to see our own Casey Orvin on site at World Vaccine Congress Europe! If you’re attending, connect with Casey to talk partnerships, pipeline support, and what’s ahead for Alcanza in vaccine development. 🔸Connect with our team at bd@alcanzaclinical.com The World Vaccine Congress - Europe October 13–17 | Amsterdam #WVCEU

We’re grateful for our continued collaboration with Alleviate Health, a valued patient recruitment partner for the Alcanza site network. Their support has played a pivotal role in helping us improve access to clinical research in the communities we serve.

At Alcanza, we honor Hispanic Heritage Month by celebrating the strength, culture, and contributions of the Hispanic community, both within our organization and across the broader clinical research landscape. Our mission is grounded in being inclusive, compassionate, and determined-- values that deeply resonate with the rich legacy of Hispanic communities who continue to shape science and our society in much needed ways. We remain committed to creating more #equitable access to clinical trials and building research partnerships that reflect the diversity of the populations we serve. #hispanic #clinicalresearch #forall

We've had a few days to reflect and recover from the phenomenon of #SCRS2025! From the speaking sessions and new connections to embracing longtime colleagues, this year was another for the record books in the sense of "together we build." We hope the months ahead are sustained with the buzz of creating exciting new dyanmics in #clinicalresearch. See you next year! Society for Clinical Research Sites (SCRS) Carlos E. Orantes Casey Orvin

It doesn’t get better than this group in this space. Alcanza Clinical Research #SCRS2025

At Alcanza, we believe the future of clinical research isn’t built alone. It’s built together: sites, sponsors, CROs, solution providers, all collaborating. SCRS provides exactly that space. Conversations turn into partnerships, challenges spark innovation, and shared vision becomes real progress. We invite you to join us in a game, a conversation, or a quick selfie as you navigate the exhibit hall, and connect with our team to schedule a meeting in person: Dori Sarkis, Partnerships Rachel (Flora) Benz, Early Phase Emily Degan, Manager, BD Patrick Scott, Clinical Partnerships Kara Bardram, Director of Operations Hayley Molin, AVP Regional Operations Rachel Truxall, VP Business Operations Carlos E. Orantes, CEO Casey Orvin, CCO We’re counting down the days until the SCRS Global Site Solutions Summit, and we couldn’t be more excited. #Together we build! Booth 606 | September 29 - October 1, 2025 #SCRS2025 #ClinicalResearchForAll Society for Clinical Research Sites (SCRS)

This week at DPHARM: Disruptive Innovations to Modernize Clinical Trials, our CEO Carlos E. Orantes joined panelists from 4 site networks of different sizes to explore the shift from transactional service models to integrated, long-term research collaborations between sponsors and site networks. In the session “Site Networks: Shifting from Transactional Execution to Long-Term Value,” panelists shared insights on infrastructure, scale, and the importance of deeper collaboration with sponsors. Panel participants included: • Faith Gabel, Head of Project Management, Accellacare • Suvi Gross, CEO & Co-founder, Monroe Biomedical Research • Carlos E. Orantes, CEO, Alcanza Clinical Research • Mark Scullion, CEO, Atlas Clinical Research • Moderated by Adam Kinsey, Associate VP, Clinical Operations, Regional Head Latin America, Merck Panelists shared a clear message: by aligning investments and long-term goals, site networks and sponsors can build a more integrated and impactful clinical research model.

Alcanza's Carlos E. Orantes was a featured panelist yesterday at "Optimizing the CRO/Site Partnership: Bridging Operational Gaps for Trial Success" for a Partnerships with Sites forum. During the session, panelists reaffirmed a common theme across the industry: sites, sponsors, and CROs are aligned in the call for greater communication and transparency throughout study planning, activation, and execution. Another key trend discussed was the evolving site landscape. With more multi-site organizations emerging, sponsors and CROs have new opportunities to engage with partners who offer operational scale and consistency across geographies. Thank you to our fellow panelists for a thoughtful and productive discussion: • Facilitator: Carrie Lewis, Endo • Amanda Baer, MBA, University of Pennsylvania • Kathleen Frenia Cohen, Avalo Therapeutics • Rebecca Sayers, PhD, IQVIA Alcanza brought forward the voice of the integrated site network, reinforcing how strategic collaboration and centralized infrastructure can streamline trial delivery across diverse patient populations. We appreciated the opportunity to contribute to this important conversation.